The recent surge in prescriptions for ivermectin and fenbendazole, two antiparasitic drugs, has sparked curiosity and concern. The surge was triggered by actor Mel Gibson's claim on the Joe Rogan Experience podcast that these drugs can treat cancer. While the story has spread rapidly online, it's important to approach it with caution and a critical eye. Here's why:
The Science of Ivermectin and Fenbendazole
Ivermectin, a widely prescribed antiparasitic drug, has shown promise in laboratory studies. It may interfere with a pathway that helps cancer cells survive and make tumors easier for the immune system to detect and destroy. However, laboratory findings don't automatically translate to successful treatments for patients. No studies have yet examined the effectiveness of ivermectin in cancer patients, although early-stage trials are underway.
Fenbendazole, on the other hand, is only used in animals and not approved for human use. In laboratory studies, it has shown potential by disrupting cancer cells' glucose uptake, impairing their ability to manage chemical stress, and damaging their structure. However, the story of a US businessman claiming fenbendazole helped him recover from lung cancer was later found to be incomplete, as he was also receiving experimental treatment and other drugs.
The Evidence Gap
The central issue lies in the quality of the evidence. Most evidence supporting ivermectin and fenbendazole as cancer treatments comes from studies in cells or animals, not from clinical trials involving patients. A retracted paper claiming major improvements in three cancer patients taking fenbendazole highlights the reliability concerns. Additionally, there's no scientific evidence supporting the combination of these two drugs as a cancer treatment.
The Need for Caution
While interest in these drugs has grown quickly, and some human trials are underway, it's crucial to remember that these drugs are still considered experimental cancer treatments. Medical experts recommend relying on evidence-based cancer treatments supported by clinical research. Until large, well-conducted trials are completed, it's unwise to assume these drugs are a miracle cure.
The Human Element
Cancer can leave people desperate for hope, and stories about familiar, low-cost drugs can spread rapidly online. However, it's essential to approach these claims with skepticism and rely on evidence-based medicine. The potential for misuse and misinformation is real, and responsible reporting and scientific scrutiny are vital to ensure patient safety.
